Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Carsten Boye Knudsen"'
Autor:
Mikkel Askjær Agersnap, Kim Sonne, Kim Mark Knudsen, Carsten Boye Knudsen, Mark Berner-Hansen
Publikováno v:
Clinical Drug Investigation. 42:1093-1100
Glepaglutide is a novel, long-acting, glucagon-like peptide-2 analogue in a stable aqueous formulation for subcutaneous dosing to treat patients with short bowel syndrome. This study was conducted primarily to characterise the pharmacokinetics of gle
356-P: Population Pharmacokinetic Modeling of Dasiglucagon in Subjects with Type 1 Diabetes Mellitus
Autor:
Stine Just Maarbjerg, Paul M. Diderichsen, Han Witjes, Anders H. Valeur, Carsten Boye Knudsen, Ramin Tehranchi
Publikováno v:
Diabetes. 70
To quantify the impact of subject covariates on pharmacokinetics (PK) of the novel, ready-to-use glucagon analog dasiglucagon, we developed a population PK model. Dasiglucagon pharmacokinetics was dose linear in the tested dose range (0.1 to 1.0 mg)
Autor:
Kirsten Nørgaard, Carsten Boye Knudsen, Sten Madsbad, Signe Schmidt, Jens J. Holst, John Bagterp Jørgensen, Henrik Madsen, Sabrina Lyngbye Wendt, Ajenthen Ranjan
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 122:322-330
Hypoglycaemia remains the main limiting factor in type 1 diabetes management. We developed an insulin-dependent glucagon dosing regimen for treatment of mild hypoglycaemia based on simulations. A validated glucose-insulin-glucagon model was used to d
Autor:
Sabrina Lyngbye Wendt, Jan Kloppenborg Møller, Ahmad Haidar, Britta Væver Bysted, Carsten Boye Knudsen, Henrik Madsen, John Bagterp Jørgensen
Publikováno v:
Wendt, S L, Møller, J K, Haidar, A, Bysted, B V, Knudsen, C B, Madsen, H & Jørgensen, J B 2016, ' Model of the Glucose-Insulin-Glucagon Dynamics after Subcutaneous Administration of a Glucagon Rescue Bolus in Healthy Humans ' The American Diabetes Association's 76th Scientific Sessions (ADA 2016), New Orleans, Louisiana, United States, 10/06/2016-14/06/2016, .
Technical University of Denmark Orbit
Technical University of Denmark Orbit
In healthy individuals, insulin and glucagon work in a complex fashion to maintain blood glucose levels within a narrow range. This regulation is distorted in patients with diabetes. The hepatic glucose response due to an elevated glucagon level depe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b70c8a486d78bc36fddeba828a32a812
http://orbit.dtu.dk/ws/files/124207434/abstract_ada16_slw_final.pdf
http://orbit.dtu.dk/ws/files/124207434/abstract_ada16_slw_final.pdf
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 306:1191-1199
Antiarrhythmic peptides (AAPs) are a group of compounds with antiarrhythmic properties; however, their use has been hampered by very low plasma stability. The aim of this study was to compare the in vitro and in vivo stability of our new stable AAP a
Publikováno v:
Analytical Biochemistry. 265:167-175
An on-line capillary electrophoresis–mass spectrometry method (CE–MS) for the detection of metallothionein (MT) isoforms is described. The detected masses were usually within 1–1.5 mass units of the expected molecular weights. MT-containing sam
Publikováno v:
Journal of cardiovascular pharmacology. 44(1)
Non-pharmacological in vivo models of atrial fibrillation (AF) have been developed in large animals only. We aimed to develop and characterize a new small animal non-pharmacological in vivo model of AF. AF was induced by transesophageal atrial burst
Autor:
Steen Mencke, Henning Beck-Nielsen, Hans Jørgen Gjessing, Klaus Levin, Carsten Boye Knudsen, Peter Thye-Rønn
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 104:178-179
Autor:
Sabrina Lyngbye Wendt, Ajenthen Ranjan, Jan Kloppenborg Møller, Carsten Boye Knudsen, Jens Juul Holst, Sten Madsbad, Henrik Madsen, Kirsten Nørgaard, John Bagterp Jørgensen
Publikováno v:
Technical University of Denmark Orbit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::524b4f68f7c8c2168861a056f86280d5
https://orbit.dtu.dk/en/publications/2b7396c5-3e12-4fe7-a5c1-b389088bb91f
https://orbit.dtu.dk/en/publications/2b7396c5-3e12-4fe7-a5c1-b389088bb91f
Autor:
Sabrina Lyngbye Wendt, Carsten Boye Knudsen, John Bagterp Jørgensen, Henrik Madsen, Ahmad Haidar
Publikováno v:
Technical University of Denmark Orbit
Wendt, S L, Boye Knudsen, C, Jørgensen, J B, Madsen, H & Haidar, A 2016, ' Modelling the glucose-insulin-glucagon dynamics after subcutaneous administration of native glucagon and a novel glucagon analogue in dogs ' 9th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2016), Milan, Italy, 03/02/2016-06/02/2016, .
Wendt, S L, Boye Knudsen, C, Jørgensen, J B, Madsen, H & Haidar, A 2016, ' Modelling the glucose-insulin-glucagon dynamics after subcutaneous administration of native glucagon and a novel glucagon analogue in dogs ' 9th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2016), Milan, Italy, 03/02/2016-06/02/2016, .
Zealand Pharma has invented a glucagon analogue, ZP-GA-1, with increased stability in liquid formulation for treatment of hypoglycemia. A pharmacodynamic (PD) model is needed to compare ZP-GA-1 with marketed glucagon. We aim to develop a model of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::015258276fbc14d06d53bf796289d70d
https://orbit.dtu.dk/en/publications/53d1edd3-8bc6-4d8d-af0a-3fb68eed5658
https://orbit.dtu.dk/en/publications/53d1edd3-8bc6-4d8d-af0a-3fb68eed5658